[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Obstetrics and gynaecology](https://durgical.com/en/obstetrics-gynaecology/) › [Gynaecological oncology](https://durgical.com/en/obstetrics-gynaecology/areas/gyn-oncology/) › Breast cancer screening in Colombia

# Breast cancer screening in Colombia

- Routine care

[Breast cancer](https://durgical.com/en/conditions/breast-cancer/) is the most common cancer in women worldwide. Found small, it is usually curable; finding it small is the whole point of screening.

Updated Nov 19, 2026

**See it in 3D:** [Mammary gland lobes](https://durgical.com/en/anatomy/mammary-gland/) · [Lactiferous ducts](https://durgical.com/en/anatomy/lactiferous-ducts/) · [Nipple](https://durgical.com/en/anatomy/nipple/)

## Key points

- [Res. 3280](https://durgical.com/en/obstetrics-gynaecology/the-well-woman-visit-by-age-screening-vaccines-and-counselling/): clinical breast exam yearly from 40.
- Res. 3280: two-view mammogram every two years from 50 to 69.
- BI-RADS 4 and 5 = biopsy with priority; 3 = follow-up.
- Self-exam = awareness, not screening.
- Symptoms at any age = diagnostic workup, not screening.
- High risk (BRCA, chest radiation when young, lifetime risk about 20% or more): earlier screening with yearly MRI added.

On this page

- The basics Key points
- What it is
- How to think about it
- What it looks for
- How it is done
- BI-RADS categories that are easy to confuse
- Common mistakes
- Next step / When to refer
- Common traps
- Elsewhere in DurgiPedia

- Study Test yourself

- Connections Connections

## What it is

Screening looks for breast cancer in women without symptoms. In Colombia, Resolución 3280 de 2018 (Ruta de Promoción y Mantenimiento de la Salud) sets a [clinical breast examination](https://durgical.com/en/clinical-exam/clinical-breast-examination/) every year from 40 and a two-view mammogram every two years from 50 to 69. Results are reported in BI-RADS categories: normal or benign results continue the schedule, probably benign findings follow the breast cancer care route, and suspicious ones lead to an active search for the woman and a priority biopsy. Women with hereditary or family risk factors are referred to the breast cancer care route. Self-examination is taught as awareness of warning signs, not as a substitute for screening. A woman with symptoms is not screened: she gets a diagnostic workup at any age. How intensely to screen depends on risk. Risk models estimate it from the history: the Gail model uses age, age at first period and first birth, previous breast biopsies (especially atypical hyperplasia), race or ethnicity and first-degree relatives with breast cancer, and gives a five-year and lifetime risk; the Tyrer–Cuzick model adds a detailed family tree, hormonal factors and breast density, so it suits women with a family history better. High risk means a known [BRCA1](https://durgical.com/en/conditions/hereditary-breast-and-ovarian-cancer-syndrome/), BRCA2 or other high-penetrance variant (or an untested first-degree relative of a carrier), chest radiation between about 10 and 30 years of age (for example for [Hodgkin lymphoma](https://durgical.com/en/conditions/hodgkin-lymphoma/)), or an estimated lifetime risk of about 20% or more. These women start earlier, usually from about 25 to 30, with a yearly breast MRI added to mammography, because MRI is the most sensitive test and is not blinded by dense tissue; it is not used for average-risk women because it brings many false alarms and biopsies.

## How to think about it

Think of screening as nets with finer and finer mesh. Her own awareness catches changes she can see or feel; the clinical exam catches lumps a trained hand finds; mammography catches cancers too small to feel, such as clusters of microcalcifications. A finer mesh also catches more harmless things (false alarms, biopsies). The age rules mark where the finer net starts to catch enough cancers to be worth its false alarms: hand from 40, mammogram from 50 to 69.

## What it looks for

- From 40: clinical breast examination every year (Res. 3280 de 2018).
- From 50 to 69: two-view mammogram every two years; with a normal or benign result (BI-RADS 1 or 2), continue every two years until 69.
- BI-RADS 3: further diagnostic or follow-up steps as the breast cancer care route defines.
- BI-RADS 4A, 4B, 4C or 5: actively find the woman, give a priority results appointment and order a biopsy.
- The history looks for hereditary, family and personal risk factors; if present, refer to the breast cancer care route.
- Warning signs to teach: a lump in the breast or armpit, skin thickening or retraction, colour change, new [nipple](https://durgical.com/en/anatomy/nipple/) retraction, new asymmetry, ulcers, and spontaneous or bloody [nipple discharge](https://durgical.com/en/obstetrics-gynaecology/a-breast-lump-or-nipple-discharge-approach/).
- Risk models (Gail, Tyrer–Cuzick) turn the history into an estimated risk; the Gail model does not suit women with a BRCA variant, previous chest radiation or a strong family history, where Tyrer–Cuzick or a genetic assessment fits better.
- High risk (BRCA1, BRCA2 or another high-penetrance variant, chest radiation before about 30, or lifetime risk about 20% or more): yearly breast MRI plus mammography, starting earlier, planned by specialists.

## How it is done

- Ask about risk factors: family history of breast or [ovarian cancer](https://durgical.com/en/conditions/ovarian-cancer/), known BRCA variant, chest radiation when young, previous breast disease.
- Explain the purpose, benefits and possible discomfort of each test, and why she must come back for the result.
- From 40, examine both breasts and armpits in a private, calm setting, letting her say if anything hurts.
- From 50 to 69, order a two-view mammogram every two years; the result should be read and reported within 15 calendar days.
- Deliver every result and act by BI-RADS category; for 4 or 5, contact her actively and order a biopsy.
- Record the date, test and result, give her a card with the next appointment, and teach the warning signs.

## BI-RADS categories that are easy to confuse

| Category | Meaning | What happens next |
| --- | --- | --- |
| 0 | Incomplete: the image cannot be judged yet | More views or ultrasound before any conclusion |
| 1 and 2 | Normal, or a clearly benign finding | Back to routine screening every two years |
| 3 | Probably benign | Short-interval follow-up or diagnostic steps per the breast cancer route; not a biopsy by default |
| 4A, 4B, 4C | Suspicious, from low to high suspicion | Biopsy, with priority |
| [5](https://durgical.com/en/conditions/breast-cancer/) | Highly suggestive of cancer | Biopsy, with priority, and fast [referral](https://durgical.com/en/family-medicine/referral-and-counter-referral-from-the-doctor-s-side/) |
| 6 | Cancer already proven by biopsy | Treatment planning |

## Common mistakes

- Screening is for women without symptoms. A woman of any age with a lump, skin change or nipple discharge gets a diagnostic workup now, not at her next screening date.
- Under about 40, or in pregnancy and [breastfeeding](https://durgical.com/en/nursing/breastfeeding-support-latch-positions-and-common-problems/), ultrasound is the first imaging test for a lump.
- Dense breasts hide cancers on mammography; a normal mammogram does not clear a palpable lump, which needs examination, imaging and, if in doubt, a biopsy.
- Delay → a larger tumour → [spread](https://durgical.com/en/epidemiology/change-management-making-improvements-stick/) to the axillary nodes → harder treatment and lower survival; in Latin America many cancers are still found at advanced stages.
- Women at high risk (BRCA carriers, chest radiation when young) need earlier and more intensive screening planned by specialists, often with MRI.

## Next step / When to refer

- BI-RADS 4 or 5: priority biopsy (usually core needle) and referral to the breast cancer care route.
- Any palpable lump, skin retraction, new nipple inversion or bloody discharge: diagnostic imaging and referral, at any age.
- Hereditary or family risk on history: refer to the breast cancer care route and to [genetic counselling](https://durgical.com/en/biochemistry/topics/genetic-counselling-and-risk-assessment/).
- After 69: decide with the woman, by her health and preferences, whether to continue.
- High-risk woman (BRCA variant, chest radiation when young, very high estimated risk): refer to a breast specialist or high-risk clinic for earlier screening with yearly MRI and mammography.

## Common traps

- **Monthly self-examination can replace mammography**: Res. 3280 teaches it as awareness of warning signs and states plainly that it does not replace the screening tests.
- **A palpable lump with a normal mammogram is reassuring**: some cancers do not show on mammography, especially in dense breasts, so the lump needs ultrasound and often a biopsy.
- **BI-RADS 3 means probably cancer**: it means probably benign and is followed up; categories 4 and 5 are the ones that need a biopsy.
- **A 35-year-old with a lump is too young for breast cancer**: screening ages are for women without symptoms, and any woman with symptoms gets a diagnostic workup.
- **Breast MRI is the best test, so every woman should be screened with it**: MRI is the most sensitive test but gives many false positives and biopsies; it is kept for high-risk women (BRCA, chest radiation when young, lifetime risk about 20% or more), added to mammography.

## Test yourself

Think of the answer, then tap the question to see it.

## A 52-year-old with no symptoms asks what breast screening she needs in Colombia. What does Res. 3280 set?

A clinical breast examination every year and a two-view mammogram every two years, continuing to 69 if results are normal or benign.

## A screening mammogram is reported as BI-RADS 4B. What should happen next?

Find the woman actively, give her a priority results appointment and order a biopsy; 4 means suspicious.

## A 38-year-old has felt a lump for a month. Her friend says she is too young for screening. What is the right approach?

She is not being screened but investigated: any woman with a breast symptom needs a diagnostic workup now, usually ultrasound first at her age, and biopsy if indicated.

## Why does a normal mammogram not exclude cancer in a woman with a palpable lump?

Mammography misses some cancers, especially in dense breasts, so a lump still needs ultrasound and, if in doubt, a biopsy.

## A 28-year-old had chest radiotherapy for Hodgkin lymphoma at 16. Why does she not wait for the 50-to-69 mammogram schedule?

Chest radiation when young puts her at high risk, like a BRCA carrier: specialists plan yearly MRI plus mammography, usually from about eight years after the radiation and not before 25.

[Add to my cards (5)](https://durgical.app/estudiar/?add=/en/obstetrics-gynaecology/breast-cancer-screening-in-colombia/)

## Elsewhere in DurgiPedia

- [Mammography and breast ultrasound: BI-RADS in plain words](https://durgical.com/en/radiology/mammography-and-breast-ultrasound-bi-rads-in-plain-words/)
- [Clinical breast examination](https://durgical.com/en/clinical-exam/clinical-breast-examination/)
- [Breast: ducts, lobules and changes with life stage](https://durgical.com/en/histology/breast-ducts-lobules-and-changes-with-life-stage/)
- [Principles of screening](https://durgical.com/en/epidemiology/principles-of-screening/)
- [Screening in women's health: cervical cancer, breast cancer and the Res. 3280 schedule](https://durgical.com/en/nursing/screening-in-women-s-health-cervical-cancer-breast-cancer-and-the-res-3280-sched/)

## Connections

## See it in 3D 3

The structures of Durgical's 3D anatomy where it is found.

- [Mammary gland lobes](https://durgical.com/en/anatomy/mammary-gland/)
- [Lactiferous ducts](https://durgical.com/en/anatomy/lactiferous-ducts/)
- [Nipple](https://durgical.com/en/anatomy/nipple/)

## Related 3

- [A breast lump or nipple discharge: approach](https://durgical.com/en/obstetrics-gynaecology/a-breast-lump-or-nipple-discharge-approach/)
- [BRCA and Lynch syndrome: who to test and risk-reducing options](https://durgical.com/en/obstetrics-gynaecology/brca-and-lynch-syndrome-who-to-test-and-risk-reducing-options/)
- [Cervical cancer screening with HPV testing in Colombia](https://durgical.com/en/obstetrics-gynaecology/cervical-cancer-screening-with-hpv-testing-in-colombia/)

## Related conditions 3

- [Breast cancer](https://durgical.com/en/conditions/breast-cancer/)
- [Fibrocystic breast changes](https://durgical.com/en/conditions/fibrocystic-breast-changes/)
- [Hereditary breast and ovarian cancer syndrome (BRCA1/BRCA2)](https://durgical.com/en/conditions/hereditary-breast-and-ovarian-cancer-syndrome/)

[← All of obstetrics and gynaecology](https://durgical.com/en/obstetrics-gynaecology/)

Educational content; it does not replace assessment by a doctor or your institution's protocols, and it contains no doses. For heavy bleeding, a severe headache or blurred vision, a seizure, fever, strong abdominal pain or fewer baby movements, go to an emergency department at once.

Sources: [Resolución 3280 de 2018: lineamientos técnicos y operativos de la Ruta de Promoción y Mantenimiento de la Salud y de la Ruta Materno Perinatal](https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/resolucion-3280-de-2018.pdf) (Ministerio de Salud y Protección Social de Colombia, 2018); [Breast Cancer Screening in the Average-Risk Patient](https://www.ncbi.nlm.nih.gov/books/NBK556050/) (StatPearls Publishing (NCBI Bookshelf), 2024); [Screening Mammography in Breast Cancer Detection](https://www.ncbi.nlm.nih.gov/books/NBK559310/) (StatPearls Publishing (NCBI Bookshelf), 2023); [Breast cancer (fact sheet)](https://www.who.int/news-room/fact-sheets/detail/breast-cancer) (World Health Organization, 2026); [Breast MRI in Clinical Practice](https://www.ncbi.nlm.nih.gov/books/NBK539727/) (StatPearls (NCBI Bookshelf), 2023); [BRCA Gene Changes: Cancer Risk and Genetic Testing](https://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet) (National Cancer Institute, 2024).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/obstetrics-gynaecology/breast-cancer-screening-in-colombia/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/obstetrics-gynaecology/breast-cancer-screening-in-colombia/
